BBNX

NASDAQStock

Beta Bionics, Inc.

$10.39+0.28 (+2.77%)

52-Week Range

$9.71

$31.99

Key Stats

Market Cap

461.1M

P/E Ratio

—

Dividend Yield

—

Beta

5.60

Volume

547.9K

Avg Volume

1.1M

Performance

-25.39%

-65.98%

-60.06%

YTD

-65.44%

-31.08%

-57.22%

Price Chart

ETF Exposure

BBNX is held by 56 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	5	$51	$9.3M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	60	$1K	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,161	$40K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	10	$195	$337.7M	0.32%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	51,188	$43K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	51,188	$13K	$3.91B	0.07%

PreviousPage 2 of 2

About BBNX ETF Exposure

Beta Bionics, Inc. (BBNX) is held by 56 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 461.1M, BBNX is a widely held institutional stock. The stock currently trades at $10.39. Investors can gain exposure to BBNX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BBNX, sorted by portfolio weight.